Effect of Pre-dosing With Methylcellulose or Psyllium on Colonic Fermentation of Inulin

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-31

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim for this pilot study is to test the hypothesis that pre-dosing with gel-forming dietary fibres (methylcellulose or psyllium) will alter the colonic fermentation of a model fermentable dietary fibre (Inulin) when delivered separately, in contrast to our previous trials where gel-forming and fermentable dietary fibres were co-administered. Performance of each gel-forming dietary fibre will be compared to placebo (water) to assess treatment effectiveness.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Rate Of Delivery on Colonic Fermentation of inuliN (EON)

NCT05619341

Irritable Bowel

COMPLETED NA

Effect of Methylcellulose or Psyllium on Fermentation of inUlin Assessed USing MRI

NCT06291272

Colon, Irritable

COMPLETED NA

Tolerance and Utilization of Polydextrose, Inulin, and Soluble Corn Fiber

NCT02091349

Tolerance

COMPLETED NA

Effect of Consumption of Orafti® Inulin on Bowel Motor Function in Subjects With Constipation

NCT02548247

Healthy Constipation

COMPLETED NA

Fibers and Gut Health

NCT02234518

Constipation

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

4\. BACKGROUND AND RATIONALE

The challenge is to understand how various dietary fibres interact to alter colonic fermentation of FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) with the aim of reducing gaseous distension of the colon and hence symptoms. Previous studies 1 have shown how psyllium, a gel forming natural fibre can reduce gas production induced by a dietary FODMAP inulin when it reaches the colon. The investigation will exploiting a range of food grade modified celluloses which can form gels at body temperature to perform human studies to explore whether the beneficial effect of psyllium is unique or will be found with all gelling substances 2.

The mode of action of methylcellulose and psyllium on the reduction in gas production from inulin remains unclear. Possible mechanisms include 1) slowing delivery to the colon by their effect in the small bowel, 2) delayed release of inulin from the dietary fibre gel matrix (i.e. a physical effect) in the colon 3) or a direct effect on the colonic bacteria reducing their production of gas (i.e. a microbiological effect).

References

Aim This pilot study will test the hypothesis that pre-dosing with gel-forming dietary fibres (methylcellulose or psyllium) will alter the colonic fermentation of a model fermentable dietary fibre (Inulin) when delivered separately, in contrast to our previous trials where gel-forming and fermentable dietary fibres were co-administered. Performance of each gel-forming dietary fibre will be compared to placebo (water) to assess treatment effectiveness.

Objective The primary objective of this pilot is to compare the effect of pre-feeding a gel-forming dietary fibre (methylcellulose or psyllium) compared to placebo (water) on the colonic fermentability of Inulin over the six hours immediately post inulin ingestion as assessed from breath hydrogen production.

Secondary Objectives

1. Area under curve (AUC) of breath hydrogen and methane for period 0 - 24hr.
2. Orocecal transit time (OCTT) from breath analysis.
3. Whole gut transit time assessed by blue muffin test.
4. Gas production with in vitro model of colon using participants stool samples (Quadram Institute).
5. Metabolite production (short chain fatty acids) using same in vitro model of colon (Quadram Institute).
6. Analysis of microbiota in participants stool using 16sRNA gene (in collaboration with Quadram Institute).
7. Assessment of habitual dietary FODMAP intake on breath hydrogen response to Inulin

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Irritable Bowel Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

randomised placebo controlled crossover study

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

gels given in opaque plastic bag

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Psyllium

15g psyllium + 15 inulin dissolved in 250 ml water

Group Type ACTIVE_COMPARATOR

inulin

Intervention Type OTHER

inulin from chicory root

Methylcelulose

15g methylcellulose +15 g inulin dissolved in 250 ml water

Group Type ACTIVE_COMPARATOR

inulin

Intervention Type OTHER

inulin from chicory root

Maltodextrin

15g maltodextrin +15 g inulin dissolved in 250 ml water

Group Type PLACEBO_COMPARATOR

inulin

Intervention Type OTHER

inulin from chicory root

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

inulin

inulin from chicory root

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged between 18 and 65 years old.
* Able to give informed consent.
* Scoring ≤5 (i.e., mild, or less) for symptoms of flatulence, bloating, abdominal pain, loose stool, and hard stool in previous 2 weeks using a modified Gastrointestinal Symptom Rating Scale (5).
* Agrees to consume the meals provided.
* Agrees to not smoke during the breath hydrogen sampling period.

Exclusion Criteria

* • Pregnancy, lactating, or planning pregnancy during the course of the investigation declared by candidate.

* History declared by the candidate of pre-existing gastrointestinal disorder that may affect bowel function.
* Reported history of previous resection of the oesophagus, stomach, or intestine (excluding appendix).
* Intestinal stoma.
* Any medical condition making participation potentially compromising participation in the study e.g., diabetes mellitus, respiratory disease limiting ability to use breath hydrogen analyser, known intolerance to one of the test substances.
* Has a body mass index (BMI) value less than 18.5 or greater than 35.
* Will not agree to follow dietary and lifestyle restrictions required.
* Participants who are taking antibiotics or probiotics as it might alters gut microbiota.
* Poor understanding of English language.
* Participation in night shift work the week prior to the study day. Night work is defined as working between midnight and 6.00 AM.
* Anyone who in the opinion of the investigator is unlikely to be able to comply with the protocol e.g., cognitive dysfunction, chaotic lifestyle related to substance abuse.
* Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes